SynthesisArquivos de neuro-psiquiatria2025

Efficacy and safety of glucagon-like peptide 1 agonists for Parkinson's disease: a systematic review and meta-analysis.

Luis O S Nogueira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.